{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lincoln",
      "state": "NE",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65840",
      "recalling_firm": "Novartis Consumer Health",
      "address_1": "10401 Hwy 6",
      "address_2": "N/A",
      "postal_code": "68517-9626",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide, Canada, and Panama.",
      "recall_number": "D-909-2013",
      "product_description": "Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Mint flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON  L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10091 3.",
      "product_quantity": "23,856 bottles",
      "reason_for_recall": "Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.",
      "recall_initiation_date": "20130806",
      "center_classification_date": "20130820",
      "termination_date": "20141104",
      "report_date": "20130828",
      "code_info": "Lot #: 10107000, Exp 07/13; 10114319, Exp 01/14"
    }
  ]
}